Santhera Pharmaceuticals Holding AG

XSWX:SANN (Switzerland)  
CHF 9.25 (-1.39%) Apr 12
At Loss
Market Cap:
CHF 108.02M ($ 118.16M)
Enterprise V:
CHF 147.86M ($ 161.74M)
Volume:
15.95K
Avg Vol (2M):
26.84K
Also Trade In:
Volume:
15.95K
At Loss
Avg Vol (2M):
26.84K

Business Description

Description
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.04
Equity-to-Asset -0.68
Debt-to-Equity -0.97
Debt-to-EBITDA -1.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -16.55
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.19
9-Day RSI 33.93
14-Day RSI 38.55
6-1 Month Momentum % 30.31
12-1 Month Momentum % 50.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.14
Quick Ratio 0.14
Cash Ratio 0.02
Days Inventory 25
Days Sales Outstanding 79.05
Days Payable 583.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -80.7
Shareholder Yield % -3.93

Financials

XSWX:SANN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Santhera Pharmaceuticals Holding AG Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 5.162
EPS (TTM) (CHF) -8.63
Beta -1.53
Volatility % 56.12
14-Day RSI 38.55
14-Day ATR (CHF) 0.359579
20-Day SMA (CHF) 9.574
12-1 Month Momentum % 50.15
52-Week Range (CHF) 6.04 - 14.62
Shares Outstanding (Mil) 11.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Santhera Pharmaceuticals Holding AG Filings

Filing Date Document Date Form
No Filing Data

Santhera Pharmaceuticals Holding AG Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

Santhera Pharmaceuticals Holding AG Frequently Asked Questions

What is Santhera Pharmaceuticals Holding AG(XSWX:SANN)'s stock price today?
The current price of XSWX:SANN is CHF9.25. The 52 week high of XSWX:SANN is CHF14.62 and 52 week low is CHF6.04.
When is next earnings date of Santhera Pharmaceuticals Holding AG(XSWX:SANN)?
The next earnings date of Santhera Pharmaceuticals Holding AG(XSWX:SANN) is .
Does Santhera Pharmaceuticals Holding AG(XSWX:SANN) pay dividends? If so, how much?
Santhera Pharmaceuticals Holding AG(XSWX:SANN) does not pay dividend.

Press Release

Subject Date
No Press Release